GSK faces probe over bribery claims

GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, adding to problems for a company already accused of corruption in China and Iraq.

Poland’s Central Anti-Corruption Bureau, or CBA, said yesterday that 13 people had been charged in connection with the investigation launched by Polish prosecutors.

Britain’s biggest drugmaker said one employee had been disciplined following a company probe and it was co-operating with the Polish authorities.